Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Louis Reed

Eberechi Eze staggers Mansfield as Arsenal survive FA Cup scare

Goals from Noni Madueke and Eberechi Eze gave Arsenal a 2-1 win at Mansfield and a place in the quarter-finals of the FA Cup

The Guardian - UK · Mar 7

Mansfield vs. Arsenal: Preview, Predictions and Lineups

Arsenal have been gifted a golden ticket into the FA Cup quarterfinals.

Sports Illustrated · Mar 7

Louis Reed ‘took his moment’ to fire Mansfield past Burnley in the FA Cup

Reed netted the winner from a late free-kick to earn the Stags a 2-1 victory.

The Independent UK · Feb 14

From analysis to the latest developments in health,
read the most diverse news in one place.

Burnley turfed out of FA Cup on perfect day for Louis Reed and Mansfield

Rhys Oates was also on target for Mansfield in the League One side’s 2-1 FA Cup fourth round victory at Burnley, who took a first-half lead through Josh Laurent

The Guardian - UK · Feb 14

Louis Reed’s free-kick earns perfect FA Cup day for Mansfield against Premier League Burnley

The Stags arrived at Turf Moor on a five-game winless run but they fought back from a goal down

The Independent UK · Feb 14

Twelve mind-blowing facts about the criminal justice system — and the best ways to fix it

Problems remain well-known and abundant in the justice system, but activists are describing new research and new approaches at day two of the American Workforce and Justice Summit, Josh Marcus writes

The Independent UK · May 6, 2022

Cybin's CYB0004 Shows Positive Preclinical Results Over Traditional Psychedelics

CYB004 is one of Cybin’s (NYSE:CYBN) proprietary second-generation psychedelics, developed to treat depression, anxiety, and substance abuse disorders. According to the company, the substance has recently shown positive preclinical data over DMT, the molecule from which it is derived. Cybin has observed that the preclinical study showed promising results for…

Benzinga · Apr 13, 2022

Read news from The Economist, FT, and more,
with one subscription

Cybin Begins Study Using Kernel Flow Headsets To Measure Ketamine's Effects On The Brain

The first study visit to measure the psychedelic effects of ketamine in the cerebral cortex blood flow is underway, announced Cybin Inc. (NYSE:CYBN), which is sponsoring the research that will make heavy use of Kernel Flow, a quantitative neuroimaging technology. Without the need for a more expensive and oversized piece of equipment, Kernal Flow…

Benzinga · Mar 31, 2022

Numinus Administers MDMA To First Volunteer In Clinical Trial Sponsored By MAPS

Numinus Wellness Inc. (OTCQX:NUMIF), announced that clinical trial MAPPUSX has gotten underway with the enrolling and dosing of the first trial volunteer in Canada. MAPPUSX, which stands for "A multi-site open-label extension study of MDMA-assisted psychotherapy for PTSD”, is sponsored by the Multidisciplinary Association for Psychedelic Studies (MAPS) and organized by…

Benzinga · Mar 30, 2022

Cybin Completes In Vivo Preclinical Studies For Major Depressive Disorder

Cybin Inc. (NYSE:CYBN) announced that its in vivo preclinical studies evaluating the proprietary drug CYB003 are completed. The goal is to analyze the potential of the compound in treating major depressive disorder (MDD). The studies were carried out on multiple species and included several doses of the substance, which were reportedly…

Benzinga · Mar 29, 2022

Ketamine Could Help Treat Parkinson's Disease, Study Finds

PharmaTher Holdings Ltd. (OTCQB:PHRRF) announced positive results from a clinical study of ketamine for the treatment of levodopa-induced dyskinesia (LID) in patients with Parkinson’s disease. The study, called KET-LID, evaluated the safety, tolerability and efficacy of low-dose ketamine infusion for the treatment of LID in patients with Parkinson’s disease. According…

Benzinga · Mar 24, 2022

Backtalk to the future

Early in The Adam Project, a pipsqueak asthmatic named Adam (Walker Scobell) and his golden retriever gallivant through the woods among shimmering falling debris. The cause of the wreckage, Adam learns, is a time jet that was crash-landed by his older self (Ryan Reynolds) travelling from the future. This is…

Bangkok Post · Mar 17, 2022

Coverage From

People

Crysencio Summerville

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.